FDA Compliance 2012 - Validation of Existing/ Legacy Computer Systems for FDA/EU Compliance
Date2012-05-23
Deadline2012-05-23
VenuePalo Alto, USA - United States
KeywordsLegacy Systems; Computer System Validation; CSV; FDA Compliance; EU Compliance; Part 11; New Annex 11; retrospective validation; GAMP recommendations
Topics/Call fo Papers
This webinar on validating legacy computer systems will give a good understanding of FDA and EU regulatory requirements for validation (retrospective validation) and provide tools for effective implementation.
Why Should You Attend:
When existing or legacy computer systems are used in FDA or equivalent international environments they should be validated, a process sometimes called retrospective validation. While the industry is very well familiar with the validation of new systems, there are many questions about existing or legacy systems.
Learning Objectives:
- Definition of legacy systems and retrospective validation.
- FDA requirements and inspection practices.
- Examples of FDA warning letters.
- Industry recommendations, e.g., from the GAMP.
- Assessment activities, e.g., gap analysis and risk assessment.
- Reviewing and updating the validation master plan for existing systems.
- Going through the validation lifecycles from planning to ongoing tests in routine use.
- Documenting validation results for FDA/EU compliance.
- Dealing with requirements for electronic records/signatures: Part 11, New Annex 11.
Other CFPs
- How to Survive the FDA Design Control Inspection: Common Problems and Risk mitigation
- How to Organize and Conduct Product Complaint Investigations
- This webinar will provide you with an overview of risk factors in clinical trials and discuss possible ways to mitigate, control, assess impact, and prevent them in your trial.
- Pre-Formulation and Formulation Development of a Sound Bio Pharmaceutical Formulation that is cGMP Compliant
- Designing Effective and Efficient Extractables/Leachables Studies for Biologics
Last modified: 2012-04-05 20:49:41